If you work in insurance innovation, partnerships, or digital transformation, you've lived this story. You find a technology company with a genuinely compelling product. The underwriting team is interested. A pilot is proposed. And then the project enters your procurement, legal, and information security processes — where it takes nine months, exhausts everyone involved, and either emerges unrecognisable or dies entirely.
The frustration is real. But the solution is not to bypass procurement. It is to design an evaluation process that is proportionate to the risk, fast enough to maintain momentum, and rigorous enough to satisfy governance. Here's how the insurers and brokers that successfully scale technology partnerships actually do it.
Why good partnerships die in procurement
The core problem is that most insurer procurement processes were designed for large, multi-year technology contracts — core system replacements, outsourcing arrangements, and major platform purchases. These processes are appropriately rigorous for a £5 million system implementation. They are grossly disproportionate for a £50,000 pilot with a telematics data provider.
The result is that a technology start-up with 30 employees is subjected to the same security questionnaire, legal review, and commercial negotiation as an enterprise software vendor with 10,000 employees. The start-up doesn't have a dedicated legal team to negotiate contract terms. It doesn't have the resources to produce six months of penetration testing reports. It may not yet hold the certifications that the standard procurement checklist requires. Each gap creates a request for more information, more documentation, more delay.
Meanwhile, the internal champion who found the technology loses patience. The budget they earmarked gets reallocated. The insurer's strategic priorities shift at the next quarterly review. By the time procurement approves the vendor, the opportunity has passed.
The tiered evaluation model
The insurers that successfully evaluate and onboard technology partners use a tiered approach that matches the depth of due diligence to the scale of the engagement:
Tier 1: Exploratory engagement (under £25,000, no live data). This covers initial pilots, proof-of-concept work using synthetic or anonymised data, and paid discovery engagements. The evaluation should be lightweight: a basic due diligence questionnaire (10–15 questions on company viability, data handling, and insurance relevance), a standard NDA, and sign-off from the business sponsor and information security lead. Timeline target: 2–4 weeks from initial contact to engagement start.
Tier 2: Pilot with live data (£25,000–£100,000, limited production access). This covers pilots that use real policyholder data or connect to production systems in a limited way. The evaluation adds a full third-party security review, a Data Processing Impact Assessment review, confirmation of GDPR compliance, and a signed data processing agreement. Commercial terms should be agreed in principle, including the criteria and process for advancing to Tier 3. Timeline target: 4–8 weeks.
Tier 3: Production deployment (over £100,000, full integration). This is where the full procurement rigour applies: comprehensive security assessment, legal contract negotiation, operational resilience review, regulatory impact assessment, and formal board or committee approval. But because Tiers 1 and 2 have already validated the technology, the commercial case, and the partnership dynamics, the Tier 3 process is faster and better-informed than if it started from scratch. Timeline target: 8–16 weeks.
Five principles for faster, better technology evaluation
1. Separate "should we explore this?" from "should we buy this?" The initial evaluation question is not "does this vendor meet all of our enterprise requirements?" It is "is there sufficient potential here to justify a time-limited, controlled exploration?" Applying production-level scrutiny to exploratory engagements kills innovation before it starts.
2. Run compliance and commercial workstreams in parallel, not in sequence. The standard process runs sequentially: commercial conversations first, then legal review, then security assessment, then procurement approval. Each stage waits for the previous one to complete. Running security and legal review in parallel with commercial discussions can cut the overall timeline by 40–60%.
3. Use a standard partner evaluation framework. Create a reusable scorecard that assesses technology partners against consistent criteria — insurance domain relevance, commercial viability, technology credibility, data governance, regulatory readiness, and integration capability. This avoids starting from scratch with every new vendor and gives leadership a consistent basis for comparison.
4. Assign a named partnership owner with decision-making authority. Not a coordinator. Not a project manager. Someone with the commercial authority to approve expenditure, the operational authority to allocate underwriting or IT resource, and the relationship authority to represent the insurer in commercial discussions. Without this person, every decision requires escalation, and escalation creates delay.
5. Define the path to production before the pilot starts. Before any pilot begins, document what a successful outcome looks like, who makes the decision to proceed, what budget is available for Phase 2, and what the integration requirements are. This doesn't commit the insurer to production deployment — it commits them to a decision process.
What to look for in a technology partner
Beyond the standard procurement criteria, the factors that differentiate technology partners who succeed in insurance from those who stall are specific and observable:
Insurance domain understanding. Can the technology company explain how their product addresses a specific insurance value chain need — in underwriting language, claims language, or distribution language? If they can only describe their technology in generic terms, they have not done the translation work required to be effective in insurance.
Compliance readiness. Can they produce a completed security questionnaire, a DPIA, and data processing terms within 48 hours of being asked? Speed of response at this stage is a reliable indicator of operational maturity.
Referenceable deployments. Do they have at least one live, referenceable insurance partnership — not a pilot, not "in discussions", but a deployed, revenue-generating relationship? If not, understand why, and assess whether the gap is a function of stage (they're genuinely early) or a red flag (they've been trying for years without success).
Financial viability. Is the company funded well enough to sustain the 12–18 month timeline that insurance partnerships typically require? A technology partner that runs out of money mid-pilot is a wasted investment.
Integration architecture. Is the product API-first, with documentation and sandbox environments? Or does every deployment require custom integration work? The former scales. The latter doesn't.
The cost of getting this wrong
There are two failure modes, and both are expensive. The first is evaluating too slowly — subjecting every technology partner to enterprise-level scrutiny, killing momentum, and building a reputation in the market as an insurer that is painful to work with. The best technology companies will choose to work with your competitors instead.
The second is evaluating too loosely — skipping due diligence, rushing to deployment, and discovering after launch that the technology partner's data governance is inadequate, their financial position is precarious, or their product doesn't integrate with your systems. The FCA's 2026 regulatory priorities make clear that effective management of outsourced partners is central to operational resilience. Getting this wrong is not just a commercial risk — it is a regulatory one.
The answer is proportionality. Match the rigour to the risk. Move quickly where the stakes are low. Be thorough where the stakes are high. And always, always have a clear path from evaluation to decision.
Evaluating technology partners for your insurance business? Take the Insurer & Broker Diagnostic → to assess whether your organisation is set up to evaluate, onboard, and scale technology partnerships effectively.